{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T01:28:13Z","timestamp":1762997293807},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.canlet.2011.07.015","type":"journal-article","created":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T15:15:43Z","timestamp":1313939743000},"page":"177-186","source":"Crossref","is-referenced-by-count":33,"title":["Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells"],"prefix":"10.1016","volume":"311","author":[{"given":"Yu-Wei","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagendra K.","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shougiang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-Fen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharam","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Fong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.07.015_b0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.canlet.2011.07.015_b0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4161\/epi.3.6.7273","article-title":"The role of histone deacetylases in prostate cancer","volume":"3","author":"Abbas","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.canlet.2011.07.015_b0015","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2011.07.015_b0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2011.07.015_b0025","first-page":"273","article-title":"Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells","volume":"48","author":"Waltregny","year":"2004","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.canlet.2011.07.015_b0030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.bjc.6604199","article-title":"Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy","volume":"98","author":"Weichert","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.07.015_b0265","unstructured":"R. Rodriguez, Sidney kimmel Comprehensive Cancer Center at Johns Hopkins, Valproic acid in Treating Patients with Progressive, Non-metastatic Prostate Cancer, National Cancer Institute NCT00670046, 2009."},{"key":"10.1016\/j.canlet.2011.07.015_b0040","first-page":"349","article-title":"Human prostatic acid phosphatases: purification of a minor enzyme and comparisons of the enzymes","volume":"16","author":"Vihko","year":"1979","journal-title":"Invest. Urol."},{"key":"10.1016\/j.canlet.2011.07.015_b0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0167-4838(84)90008-6","article-title":"Identification of structural and secretory lectin-binding glycoproteins of normal and cancerous human prostate","volume":"791","author":"Lad","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2011.07.015_b0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1677\/erc.1.00950","article-title":"Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer","volume":"12","author":"Veeramani","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2011.07.015_b0055","first-page":"293","article-title":"Studies on prostatic cancer: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.07.015_b0060","first-page":"24","article-title":"PSA and acid phosphatase in the diagnosis of prostate cancer","volume":"21","author":"Chu","year":"1998","journal-title":"J. Clin. Ligand Assay"},{"key":"10.1016\/j.canlet.2011.07.015_b0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/1097-0142(197303)31:3<689::AID-CNCR2820310331>3.0.CO;2-F","article-title":"Acid phosphatase isozymes in cancer of the prostate","volume":"31","author":"Reif","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.07.015_b0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ijc.2910550413","article-title":"Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies","volume":"55","author":"Hakalahti","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.07.015_b0075","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0022-5347(05)65725-4","article-title":"Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells","volume":"166","author":"Lin","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2011.07.015_b0080","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)36285-7","article-title":"Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma","volume":"149","author":"Sakai","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2011.07.015_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.2990130102","article-title":"Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the Gleason Grading System","volume":"13","author":"Sinha","year":"1988","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2011.07.015_b0090","first-page":"4600","article-title":"Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells","volume":"52","author":"Lin","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.07.015_b0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1432-0436.1994.5720143.x","article-title":"The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells","volume":"57","author":"Lin","year":"1994","journal-title":"Differentiation"},{"key":"10.1016\/j.canlet.2011.07.015_b0100","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1074\/jbc.273.10.5939","article-title":"Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines","volume":"273","author":"Lin","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.07.015_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj2350351","article-title":"Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity","volume":"235","author":"Lin","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2011.07.015_b0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1432-1033.1984.tb07879.x","article-title":"A phosphotyrosyl-protein phosphatase activity associated with acid phosphatase from human prostate gland","volume":"138","author":"Li","year":"1984","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.canlet.2011.07.015_b0115","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/MCB.8.12.5477","article-title":"The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase","volume":"8","author":"Lin","year":"1988","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2011.07.015_b0120","doi-asserted-by":"crossref","first-page":"22096","DOI":"10.1074\/jbc.273.34.22096","article-title":"Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells","volume":"273","author":"Meng","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.07.015_b0125","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1074\/jbc.M006661200","article-title":"Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells","volume":"276","author":"Zhang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.07.015_b0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/pros.10240","article-title":"Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase","volume":"55","author":"Igawa","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2011.07.015_b0135","doi-asserted-by":"crossref","first-page":"23598","DOI":"10.1074\/jbc.M109.098301","article-title":"Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth","volume":"285","author":"Chuang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.07.015_b0140","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1038\/sj.onc.1203576","article-title":"Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells","volume":"19","author":"Meng","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.07.015_b0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuron.2008.08.024","article-title":"Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine","volume":"60","author":"Zylka","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.canlet.2011.07.015_b0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/pros.10054","article-title":"Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model","volume":"50","author":"Igawa","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2011.07.015_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2008.08.013","article-title":"Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol","volume":"295","author":"Dillard","year":"2008","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.canlet.2011.07.015_b0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pros.20551","article-title":"Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells","volume":"67","author":"Chen","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2011.07.015_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/1097-0045(20000701)44:2<91::AID-PROS1>3.0.CO;2-L","article-title":"LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis","volume":"44","author":"Thalmann","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2011.07.015_b0170","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1038\/sj.onc.1205471","article-title":"Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter","volume":"21","author":"Zelivianski","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.07.015_b0175","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1038\/sj.onc.1208852","article-title":"Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells","volume":"24","author":"Veeramani","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.07.015_b0180","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-4781(00)00037-3","article-title":"Expression of human prostatic acid phosphatase gene is regulated by upstream negative and positive elements","volume":"1491","author":"Zelivianski","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2011.07.015_b0185","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ng.159","article-title":"Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation","volume":"40","author":"Kondo","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2011.07.015_b0190","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1582-4934.2008.00271.x","article-title":"New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma","volume":"12","author":"Wedel","year":"2008","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2011.07.015_b0195","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/MCB.01516-07","article-title":"Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter","volume":"28","author":"Wu","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2011.07.015_b0200","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0092-8674(81)90100-8","article-title":"Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells","volume":"24","author":"Hunter","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.07.015_b0205","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1016\/0303-7207(94)90025-6","article-title":"Effect of cell density on androgen regulation of the mRNA level of human prostatic acid phosphatase","volume":"99","author":"Lin","year":"1994","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.canlet.2011.07.015_b0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<49::AID-IJC10>3.0.CO;2-C","article-title":"Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus","volume":"79","author":"Pfeiffer","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2011.07.015_b0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jnci\/dji010","article-title":"Epigenetic changes in prostate cancer: implication for diagnosis and treatment","volume":"97","author":"Li","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.07.015_b0220","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2011.07.015_b0225","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.07.015_b0230","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","article-title":"Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo","volume":"66","author":"Xia","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.07.015_b0235","first-page":"1293","article-title":"Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells","volume":"32","author":"Iacopino","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2011.07.015_b0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0303-7207(95)03544-H","article-title":"The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells","volume":"111","author":"Garcia-Arenas","year":"1995","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.canlet.2011.07.015_b0245","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.10411","article-title":"Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (\u2018Iressa\u2019) is independent of EGFR expression level","volume":"198","author":"Campiglio","year":"2004","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.canlet.2011.07.015_b0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1152\/ajpgi.00182.2007","article-title":"Epidermal growth factor receptor signaling modulates apoptosis via p38alpha MAPK-dependent activation of Bax in intestinal epithelial cells","volume":"293","author":"Sheng","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2011.07.015_b0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.febslet.2004.06.018","article-title":"Histone deacetylase inhibitors regulate p21WAF1 gene expression at the post-transcriptional level in HepG2 cells","volume":"570","author":"Hirsch","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2011.07.015_b0260","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/MCB.26.7.2782-2790.2006","article-title":"Acetylation of p53 at lysine 373\/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21Waf1\/Cip1","volume":"26","author":"Zhao","year":"2006","journal-title":"Mol. Cell Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511004290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511004290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T06:42:10Z","timestamp":1560494530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511004290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0304383511004290"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.07.015","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}